| Jessica Womack, OTD | |
|
1909 214th St Se Ste 204, Bothell, WA 98021-4415 | |
| (425) 219-4788 | |
| Not Available |
| Full Name | Jessica Womack |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist - Pediatrics |
| Location | 1909 214th St Se Ste 204, Bothell, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124796040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225XP0200X | Occupational Therapist - Pediatrics | 60768049 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica Womack, OTD 23302 171st Ave Se, Monroe, WA 98272-9449 Ph: () - | Jessica Womack, OTD 1909 214th St Se Ste 204, Bothell, WA 98021-4415 Ph: (425) 219-4788 |
News Archive
IDEXX Laboratories, Inc., today reported that revenues for the first quarter of 2010 increased 14% to $268.5 million, from $236.5 million for the first quarter of 2009. Organic revenue growth, as defined below, was 9%. Earnings per diluted share for the quarter ended March 31, 2010 increased 28% to $0.55, compared to $0.43 for the same period in the prior year.
Two studies from an unusual research partnership at the University of Chicago appear to have resolved a long-standing dispute about the role of melanin in the eye. The studies, one published in the Proceedings of the National Academy of Sciences (PNAS) and one early online in the Journal of the American Chemical Society (JACS), also suggest a new way to prevent a common cause of blindness.
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genetic analysis systems, today announced that the National Institutes of Health (NIH) awarded a grant to the University of Pittsburgh that includes funding of $350,000 over the grant period for WaferGen's SmartChip™ Real-Time PCR System. The researchers will conduct novel gene expression research in the areas of advanced lung disease and asthma and will use the SmartChip system as the key platform for high throughput validation.
Gilead Sciences, Inc. today announced that its head-to-head Phase III clinical trial of Cayston (aztreonam for inhalation solution) versus tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa achieved one of its co-primary endpoints of non-inferiority for mean percent change in forced expiratory volume in one second (FEV1) percent predicted after 28 days of treatment.
Decline in lower limb function is common in older people, and worsening gait is associated with increased risk of dementia and death. However, factors contributing to gait difficulties in older persons are not well understood.
› Verified 1 days ago
Alyssa Griffin, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18504 Bothell Way Ne, Bothell, WA 98011 Phone: 425-481-1933 | |
Patricia Groebner, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3330 Monte Villa Pkwy, Bothell, WA 98021 Phone: 425-408-6062 | |
Michelle Segall Parnes, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18504 Bothell Way Ne, Bothell, WA 98011 Phone: 425-481-1933 Fax: 425-481-9371 | |
Kelly Ash, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 17204 123rd Pl Ne, Apt N203, Bothell, WA 98011 Phone: 206-787-0971 | |
Margot H Toups, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3330 Monte Villa Pkwy, Bothell, WA 98021 Phone: 425-408-7733 Fax: 425-408-7740 | |
Rhona Marlene Feldman, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 18504 Bothell Way Ne, Bothell, WA 98011 Phone: 425-481-1933 Fax: 425-481-9371 | |
Katelyn Reed, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19021 120th Ave Ne Ste 102, Bothell, WA 98011 Phone: 425-486-7710 Fax: 425-483-6059 |